Skip to main content

Pallas Capital Advisors LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1862282 BRAINTREE, MA

Position in NBIX

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$1,561,523
-$36,878 QoQ
Shares Held
9,265
-23.6% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#343
of 768 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 18% Shared 0% None 82%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Pallas Capital Advisors LLC holds $4,121,079 across 10 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (37.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
This page
9,265 $1,561,523

All Filings in NBIX

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,561,523 9,265
2026-03-31 $1,598,401 12,133
2025-12-31 $2,380,332 16,783
2025-09-30 $2,177,714 15,513
2025-06-30 $1,180,606 9,393
2025-03-31 $287,560 2,600
2024-12-31 $1,047,364 7,673
2024-09-30 $742,938 6,448
2024-06-30 $426,501 3,098
2024-03-31 $338,041 2,451